Change search
ReferencesLink to record
Permanent link

Direct link
Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Pathology.
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Pathology.
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Pathology.
Umeå University, Faculty of Medicine, Department of Surgical and Perioperative Sciences, Urology and Andrology.
Show others and affiliations
2015 (English)In: Scientific Reports, ISSN 2045-2322, E-ISSN 2045-2322, Vol. 5, 15651Article in journal (Refereed) Published
Abstract [en]

Macrophage infiltration has been associated with an improved prognosis in patients with colorectal cancer (CRC), but a poor prognosis in prostate cancer (PC) patients. In this study, the distribution and prognostic value of proinflammatory M1 macrophages (NOS2(+)) and immunosuppressive M2 macrophages (CD163(+)) was evaluated in a cohort of 234 PC patients. We found that macrophages infiltrating PC were mainly of an M2 type and correlated with a more aggressive tumor and poor patient prognosis. Furthermore, the M1/M2 ratio was significantly decreased in PC compared to CRC. Using in vitro cell culture experiments, we could show that factors secreted from CRC and PC cells induced macrophages of a proinflammatory or immunosuppressive phenotype, respectively. These macrophages differentially affected autologous T lymphocyte proliferation and activation. Consistent with this, CRC specimens were found to have higher degrees of infiltrating T-helper 1 cells and active cytotoxic T lymphocytes, while PC specimens displayed functionally inactive T cells. In conclusion, our results imply that tumour-secreted factors from cancers of different origin can drive macrophage differentiation in opposite directions and thereby regulate the organization of the anti-tumour immune response. Our findings suggest that reprogramming of macrophages could be an important tool in the development of new immunotherapeutic strategies.

Place, publisher, year, edition, pages
Nature Publishing Group, 2015. Vol. 5, 15651
National Category
Medical Bioscience
URN: urn:nbn:se:umu:diva-111473DOI: 10.1038/srep15651ISI: 000363445900002PubMedID: 26503803OAI: diva2:877510
Available from: 2015-12-07 Created: 2015-11-13 Last updated: 2015-12-17Bibliographically approved

Open Access in DiVA

fulltext(1394 kB)53 downloads
File information
File name FULLTEXT01.pdfFile size 1394 kBChecksum SHA-512
Type fulltextMimetype application/pdf
bilaga(1832 kB)6 downloads
File information
File name ATTACHMENT01.pdfFile size 1832 kBChecksum SHA-512
Type attachmentMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Lundholm, MarieHägglöf, ChristinaWikberg, Maria L.Stattin, PärBergh, AndersWikström, PernillaPalmqvist, RichardEdin, Sofia
By organisation
PathologyUrology and Andrology
In the same journal
Scientific Reports
Medical Bioscience

Search outside of DiVA

GoogleGoogle Scholar
Total: 53 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 145 hits
ReferencesLink to record
Permanent link

Direct link